Cain David — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Cain David has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Cain David

Cain David is identified in SEC filing context as a Director, CMC (Chemistry, Manufacturing and Controls) at Kazia Therapeutics Ltd as of 2026-07-08. Kazia Therapeutics Ltd is a biotechnology company focused on oncology therapies. The available SEC information provides no additional details about his background, education, or prior roles beyond the listed director and CMC responsibilities. The name could appear in sources as 'David Cain' or other variations; there is potential for name-order differences. There is no public indication in the SEC context of death or obituary related to this individual as of the filing date.

RoleDirector, CMC
Notability42/100

Board memberships

Awards & honors

Companies — Last 90 Days

Frequently Asked Questions

Who is Cain David?

Cain David is identified in SEC filing context as a Director, CMC (Chemistry, Manufacturing and Controls) at Kazia Therapeutics Ltd as of 2026-07-08. Kazia Therapeutics Ltd is a biotechnology company focused on oncology therapies. The available SEC information provides no additional details about his background, education, or prior roles beyond the listed director and CMC respo…

How many SEC Form 4 filings has Cain David submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Cain David's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Cain David profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.